EE39 Economic Evaluation of Botulinum Toxin Type A (XEOMEEN) in the Treatment of Pediatric Patients With Spasticity in the "IMSS” and “ISSSTE”
Abstract
Authors
Rosal y Hermosillo A Del Hevia J Agramonte Lopez S Vergara H. Soto-Molina Gasga AE Frias Palomo Paz EJ L.J. Peralta-Hernández Martínez F Gómez